title: Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women.
authors.affiliation: Cardiology Branch, National Institute of Health, Bethesda, Maryland, USA.
authors.forename: A
authors.initials: A
authors.lastname: Blum
authors.forename: W H
authors.initials: WH
authors.lastname: Schenke
authors.forename: L
authors.initials: L
authors.lastname: Hathaway
authors.forename: R
authors.initials: R
authors.lastname: Mincemoyer
authors.forename: G
authors.initials: G
authors.lastname: Csako
authors.forename: M A
authors.initials: MA
authors.lastname: Waclawiw
authors.forename: R O
authors.initials: RO
authors.lastname: Cannon
mesh_terms: D002097:C-Reactive Protein / Q000032:analysis; D015815:Cell Adhesion Molecules / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004966:Estrogens, Conjugated (USP) / Q000494:pharmacology; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008875:Middle Aged; D017698:Postmenopause / Q000097:blood*; D020849:Raloxifene Hydrochloride / Q000494:pharmacology*; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology*
chemical_list: D015815:Cell Adhesion Molecules; D008078:Cholesterol, LDL; D004966:Estrogens, Conjugated (USP); D008074:Lipoproteins; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride; D002097:C-Reactive Protein